140 related articles for article (PubMed ID: 11406912)
1. Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke.
Sarkar PK; Lambert LA
Int J Clin Pract; 2001 May; 55(4):262-8. PubMed ID: 11406912
[TBL] [Abstract][Full Text] [Related]
2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
Refai TM; Al-Salem IH; Nkansa-Dwamena D; Al-Salem MH
Clin Rheumatol; 2002 Nov; 21(6):457-61. PubMed ID: 12447627
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinaemia and atherothrombosis.
Cattaneo M
Ann Med; 2000 Dec; 32 Suppl 1():46-52. PubMed ID: 11209982
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
[TBL] [Abstract][Full Text] [Related]
6. [Plasma homocysteine levels in patients with ischemic heart disease].
Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
8. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
Kalita J; Kumar G; Bansal V; Misra UK
Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
10. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
12. Is plasma homocysteine a modifiable risk factor for stroke?
Hankey GJ
Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
[TBL] [Abstract][Full Text] [Related]
13. [Homocysteine--a risk factor for atherosclerosis].
Debreceni L
Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
[TBL] [Abstract][Full Text] [Related]
14. [Plasma homocysteine concentration in patients with ischaemic stroke caused by large or small vessel disease].
Turaj W; Iskra T; Pułyk R; Slowik A; Szczudlik A
Pol Merkur Lekarski; 2009 Feb; 26(152):121-4. PubMed ID: 19388516
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
[TBL] [Abstract][Full Text] [Related]
16. [Hyperhomocysteinemia. A new coronary risk factor].
Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of vascular disease in hyperhomocysteinaemia.
Domagała TB; Undas A; Libura M; Szczeklik A
J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
[TBL] [Abstract][Full Text] [Related]
19. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
20. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
